Condition: Frontotemporal Dementia · Caregiver Burden · Primary Progressive Aphasia (PPA) · Sponsor: Oregon Health and Science University
The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.
This description comes directly from the study's public registry record.
Hailey Chatterton, MS · 503-568-9725 · chatterton@ohsu.edu
Allison Lindauer, PhD, APRN · 503-494-6976 · lindauer@ohsu.edu
Always discuss trial participation with your own doctor first.
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06613204